GlaxoSmithKline PLC — Director's Dealing 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6695O

GlaxoSmithKline PLC

08 November 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Dr K Slaoui

b)

Position/status

PCA of Dr M M Slaoui (Chairman, Global Vaccines)

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

GlaxoSmithKline plc American Depositary Shares ('ADSs')

ISIN: US37733W1053

b)

Nature of the transaction

Increase in notional interest in ADSs following the allocation of ADSs as a result of the revaluation of the cash element of the notional investment held within the GSK 401(K) plan.

c)

Price(s) and

volume(s)

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2016-11-07

f)

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDVLFBQFFBFBB

//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'SbbFQxtZJsuqQ2s7by8zemKjzGgjYaYHjI9mFSxiE2yl258RT8OALCCbWbvT8FFjwTnk3iowpcKiNbm59_SK7b1m1ZzowvbNW0OCWb2rhvw1:j6-4537l_2PyGtuGJ1UNLAZdYPHv4BOH8HTxobWwsupPVyrSvX_hrgfANCbsDFuJvQ56YqS5cGMk8LEuwNZs3rYRqpQZsc6hmRhu1XeXU2M1'}});//]]>